Cody Garbrandt accused T.J. Dillashaw of using performance-enhancing drugs prior to their fight at UFC 217.
On Wednesday morning, T.J. Dillashaw announced that he had voluntarily relinquished his UFC bantamweight title after failing a drug test.
The failed drug test stems from his flyweight title bout with Henry Cejudo at UFC Fight Night 143, which Dillashaw lost via first-round technical knockout.
ESPN’s Ariel Helwani claims that Dillashaw has been suspended for one year by the New York State Athletic Commission (NYSAC), with a formal announcement expected to be made this morning.
Although it hasn’t yet been revealed what substance TJ tested positive for, it’s interesting to note that former teammate Cody Garbrandt accused Dillashaw of using performance-enhancing drugs (PEDs) back in 2017, prior to their co-headlining bantamweight championship bout at UFC 217.
Garbrandt, who lost to Dillashaw in back-to-back fights, accused Dillashaw of encouraging the use of performance-enhancing drugs at Team Alpha Male.
“Oh yea, the guys on everything,” Garbrandt said at the UFC 217 pre-fight press conference. “He’s on everything. You’re the one that showed everyone how to do it on Team Alpha Male. Look at him, he has nothing to say.”
Bloody Elbow will keep you updated on the latest news surrounding this story.